Date | Time | Source | Headline | Symbol | Company |
12/06/2018 | 5:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
12/06/2018 | 4:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
12/04/2018 | 5:53PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
12/04/2018 | 5:49PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/13/2018 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/13/2018 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/13/2018 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/13/2018 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/09/2018 | 5:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/09/2018 | 4:19PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
11/09/2018 | 4:17PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
10/30/2018 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
10/26/2018 | 4:59PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
10/26/2018 | 4:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
10/24/2018 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
10/24/2018 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
10/02/2018 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/25/2018 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/25/2018 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/25/2018 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/25/2018 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/24/2018 | 4:20PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/18/2018 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
09/04/2018 | 4:46PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
08/17/2018 | 7:01AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
08/14/2018 | 5:06PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
08/14/2018 | 5:00PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
08/07/2018 | 5:04PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
08/03/2018 | 5:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
08/03/2018 | 4:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |